[
    "{\"step_by_step_thinking\": \"Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles. Efgartigimod is a drug that has been studied for the treatment of this disease. It works by reducing the number of antibodies that can cause myasthenia gravis, thereby reducing the symptoms of the disease.\", \"answer_choice\": \"A\"}"
]